50 Million People Take Insulin The world is in the midst of a chronic shortage of endocrinologists. Primary care providers, nurses, physician assistants and others need an expert tool to properly dose insulin. Spend Time with Patients, not Data Patient visits are getting shorter. Use your time wisely. Make Meters More Useful Meters are great at collecting data, but care providers are already overwhelmed with data. Our flagship software makes patient-specific recommendations to providers so they can design optimal insulin-dosing regimens.
“Honoring your meritorious achievements and career history as both a mentor and health care provider, the Outstanding Physician-Clinician Award is one of the highest scientific awards given annually to an individual actively involved in the clinical care of patients with diabetes.” – American Diabetes Association Comprehensive dosing solutions for all patients, all regimens and all types of insulin… in seconds. Expand Access To Care Primary care physicians, nurses, and other care providers can now create and manage insulin-dosing regimens with precision. Works with all insulin types and regimens Our solution is not limited to specific regimens or only certain types of insulin. Providers can work from any insulin regimen to create optimal dosing for their patients. Clinically proven to lower HbA1c and costs of care Clinically optimal dosing leads to lower HbA1c and fewer complications from diabetes.
How It Works Our software uses glucometer data to deliver optimized, patient-specific insulin dosing recommendations in seconds. Here’s how. Patient measures blood sugar with their existing glucometer. Glucometer data is uploaded through our software or wirelessly to our cloud server. Cloud server sends patient-specific dosing recommendations to provider. Care provider reviews report and makes necessary modifications to patient insulin. Patient starts on the path to glycemic control.
Clinically Proven Algorithms Our protocols were developed over 30 years by our Chief Medical Officer, Dr. Mayer B. Davidson, MD. Maintained avg. HbA1c 7.7% in 400 inner-city patients Our protocols successfully maintained a 7.7% average HbA1c in a difficult-to-manage aging, low-income population. Blood sugar control varies significantly by income group. Dropped HbA1c from 11% to 7.2% in 110 patients in one year In a published study of a nurse managing 110 patients with our algorithms, HbA1c’s were reduced from an initial average value of 11.0% to 7.2% in just one year. Lowered HbA1c From 8.4% to 7.7% in 30 patients in 20 weeks In a published study of remote monitoring of 30 patients with diabetes, our algorithms were used to lower HbA1c levels from 8.4% to 7.7% in just 20 weeks.
Industry Support “After hearing the presentation describing your computerized insulin dose adjustment algorithms, we are very interested in evaluating them. The initial evaluation of 10 patients seemed very promising. For this reason, we look forward to working with you in the future as we develop the way in which our two systems can electronically interact.” R. James Dudl, MD | Diabetes Lead Care Management “Our Diabetes program utilizes clinical pharmacists to aid in the treatment of our diabetic patients…Therefore we would be very interested in evaluating your insulin dose adjustment algorithms after they receive 510 (k) clearance. Please let us know when this occurs.” Stephen Deutsch, MD | Chief Medical Officer “We were quite impressed with its clinical effectiveness and clearly see how this solution and tool will help our overworked primary care providers do a much better job of lowering HbA1cs for our insulin-requiring diabetic patients.” Sunday Irene, MD | Chief MedicalOfficer
Our Team Deep Medical, Management, Software, and Technical Expertise. Mayer B. Davidson, MD Chief Medical Officer Josh Davidson Chief Executive Officer Michael Margolese Chief Technical Officer Craig Lewis Chief Operating Officer Medical Advisors John Buse, MD, PhD Chief of the Division of Endocrinology, University of North Carolina Past President of the American Diabetes Association Vivian Fonseca, MD Professor of Medicine and Alumni Chair in Diabetes, Tulane University Past President of the American Diabetes Association Richard A. Kahn, PhD Professor of Medicine, University of North Carolina Past Chief Scientific and Medical Officer of the American Diabetes Association Anne Peters, MD Professor of Medicine and Director of Clinical Diabetes, USC Medical School Business Advisors Gary Hutchinson, Senior Corporate Advisors Entrepeneur in Residence, Alfred Mann Institute, USC Eric J. Weissman, Corporate Advisor President, Wilshire Capital Advisors
Contact Us
